Combined cyclophosphamide, vincristine, doxorubicin, and prednisone (CHOP) improves response rates but not survival and has lower hematologic toxicity compared with combined mitoxantrone, chlorambucil, and prednisone (MCP) in follicular and mantle c (Q33372106)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Combined cyclophosphamide, vincristine, doxorubicin, and prednisone (CHOP) improves response rates but not survival and has lower hematologic toxicity compared with combined mitoxantrone, chlorambucil, and prednisone (MCP) in follicular and mantle c |
scientific article |
Statements
1 reference
Combined cyclophosphamide, vincristine, doxorubicin, and prednisone (CHOP) improves response rates but not survival and has lower hematologic toxicity compared with combined mitoxantrone, chlorambucil, and prednisone (MCP) in follicular and mantle c (English)
1 reference
Wolfgang Hiddemann
1 reference
Hannes Wandt
1 reference
Martin Dreyling
1 reference
Michael Unterhalt
1 reference
Christina Nickenig
1 reference
Lorenz Trumper
1 reference
Marcel Reiser
1 reference
Eva Lengfelder
1 reference
German Low-Grade Lymphoma Study Group
1 reference
1 September 2006
1 reference
1 reference
Identifiers
1 reference